Bioleaders Corporation (142760) - Total Liabilities

Latest as of June 2026: ₩8.29 Billion KRW ≈ $5.62 Million USD

Based on the latest financial reports, Bioleaders Corporation (142760) has total liabilities worth ₩8.29 Billion KRW (≈ $5.62 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 142760 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Bioleaders Corporation - Total Liabilities Trend (2015–2025)

This chart illustrates how Bioleaders Corporation's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Bioleaders Corporation's balance sheet.

Bioleaders Corporation Competitors by Total Liabilities

The table below lists competitors of Bioleaders Corporation ranked by their total liabilities.

Company	Country	Total Liabilities
ABAS Protect AB ST:ABAS	Sweden	Skr44.16 Million
Ansal Properties & Infrastructure Limited NSE:ANSALAPI	India	Rs7.61 Billion
North Atlantic Smaller Companies Investment Trust PLC LSE:NAS	UK	GBX3.04 Million
Dom Maklerski IDM SA WAR:IDM	Poland	zł1.73 Million
Kolon Global Corp KO:003075	Korea	₩2.40 Trillion
Tri-Mode System M Bhd KLSE:0199	Malaysia	RM78.39 Million
Ace Oldfields PT JK:KUAS	Indonesia	Rp126.17 Billion
Electroarges S RO:ELGS	Romania	RON60.13 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Bioleaders Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 142760 net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.07	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.34	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bioleaders Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bioleaders Corporation (2015–2025)

The table below shows the annual total liabilities of Bioleaders Corporation from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩12.04 Billion ≈ $8.16 Million	-51.73%
2024-12-31	₩24.94 Billion ≈ $16.90 Million	+87.86%
2023-12-31	₩13.28 Billion ≈ $9.00 Million	-89.52%
2022-12-31	₩126.73 Billion ≈ $85.88 Million	-11.83%
2021-12-31	₩143.74 Billion ≈ $97.41 Million	-10.22%
2020-12-31	₩160.09 Billion ≈ $108.49 Million	+28.80%
2019-12-31	₩124.30 Billion ≈ $84.23 Million	-4.24%
2018-12-31	₩129.79 Billion ≈ $87.96 Million	+5284.50%
2017-12-31	₩2.41 Billion ≈ $1.63 Million	-41.92%
2016-12-31	₩4.15 Billion ≈ $2.81 Million	+4.09%
2015-12-31	₩3.99 Billion ≈ $2.70 Million	--

About Bioleaders Corporation

KQ:142760 Korea Biotechnology

Market Cap

$6.67 Million

₩9.85 Billion KRW

Market Cap Rank

#28091 Global

#2064 in Korea

Share Price

₩467.00

Change (1 day)

-0.64%

52-Week Range

₩349.00 - ₩1850.00

All Time High

₩24990.00